Brian Riesenberg

1.5k total citations · 1 hit paper
17 papers, 857 citations indexed

About

Brian Riesenberg is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Brian Riesenberg has authored 17 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Brian Riesenberg's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (6 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Brian Riesenberg is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (6 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Brian Riesenberg collaborates with scholars based in United States, China and Taiwan. Brian Riesenberg's co-authors include Zihai Li, Bei Liu, Alessandra Metelli, Bill X. Wu, Anqi Li, Chrystal M. Paulos, Mark P. Rubinstein, Caroline Wallace, Saleh Rachidi and Yi Yang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Brian Riesenberg

16 papers receiving 852 citations

Hit Papers

Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utiliz... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Riesenberg United States 13 356 321 317 125 123 17 857
Lorenzo Federico United States 15 344 1.0× 258 0.8× 517 1.6× 77 0.6× 177 1.4× 26 1.0k
Jason E. Toombs United States 21 542 1.5× 395 1.2× 554 1.7× 255 2.0× 59 0.5× 32 1.2k
Joanna W. Ho Hong Kong 15 283 0.8× 109 0.3× 638 2.0× 281 2.2× 100 0.8× 16 1.1k
Carl C. Schimanski Germany 18 718 2.0× 348 1.1× 309 1.0× 139 1.1× 96 0.8× 28 1.1k
David Cervi United States 13 377 1.1× 128 0.4× 554 1.7× 226 1.8× 65 0.5× 21 948
Sujatha Jagadeeswaran United States 12 360 1.0× 100 0.3× 465 1.5× 197 1.6× 87 0.7× 16 973
Ralf Jesnowski Germany 18 664 1.9× 140 0.4× 554 1.7× 198 1.6× 70 0.6× 35 1.1k
Emir Hadzijusufovic Austria 20 185 0.5× 467 1.5× 330 1.0× 54 0.4× 91 0.7× 53 1.3k
Karen Morrison United Kingdom 14 233 0.7× 177 0.6× 299 0.9× 88 0.7× 52 0.4× 23 826
Anne‐Laure Mathieu France 15 134 0.4× 444 1.4× 322 1.0× 62 0.5× 34 0.3× 39 901

Countries citing papers authored by Brian Riesenberg

Since Specialization
Citations

This map shows the geographic impact of Brian Riesenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Riesenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Riesenberg more than expected).

Fields of papers citing papers by Brian Riesenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Riesenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Riesenberg. The network helps show where Brian Riesenberg may publish in the future.

Co-authorship network of co-authors of Brian Riesenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Riesenberg. A scholar is included among the top collaborators of Brian Riesenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Riesenberg. Brian Riesenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hunt, Elizabeth G., Brian Riesenberg, Lauren E. Ball, et al.. (2024). Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment. Cell Metabolism. 36(5). 969–983.e10. 62 indexed citations breakdown →
3.
Riesenberg, Brian, Elizabeth G. Hunt, Lee R. Leddy, et al.. (2022). Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer. Cancer Research. 82(23). 4386–4399. 15 indexed citations
4.
Riesenberg, Brian, A. W. Andrews, Peng Gao, et al.. (2022). 1031 Acetyl CoA carboxylase inhibition rewires T cell fate and tumor immunotherapy outcome. Regular and Young Investigator Award Abstracts. A1073–A1073. 1 indexed citations
5.
Zhao, Songzhu, Mingjia Li, Sandip H. Patel, et al.. (2021). Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival. Cancer Immunology Immunotherapy. 71(5). 1157–1165. 24 indexed citations
6.
Ansa-Addo, Ephraim, Brian Riesenberg, Supinya Iamsawat, et al.. (2020). RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity. Science Advances. 6(22). eaaz3865–eaaz3865. 35 indexed citations
7.
Metelli, Alessandra, Bill X. Wu, Brian Riesenberg, et al.. (2020). Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β. Science Translational Medicine. 12(525). 91 indexed citations
8.
Li, Anqi, No‐Joon Song, Brian Riesenberg, & Zihai Li. (2020). The Emerging Roles of Endoplasmic Reticulum Stress in Balancing Immunity and Tolerance in Health and Diseases: Mechanisms and Opportunities. Frontiers in Immunology. 10. 3154–3154. 87 indexed citations
9.
Riesenberg, Brian, Mingjia Li, Daniel Spakowicz, et al.. (2020). Platelets impact the responsiveness of immune checkpoint blockade therapy in solid tumors.. Journal of Clinical Oncology. 38(15_suppl). e15023–e15023. 1 indexed citations
10.
Salem, Mohammad, Caroline Wallace, Maria Velegraki, et al.. (2019). GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon. Cancer Research. 79(6). 1178–1190. 49 indexed citations
11.
Riesenberg, Brian, Ephraim Ansa-Addo, Jennifer Gutiérrez, et al.. (2019). Cutting Edge: Targeting Thrombocytes to Rewire Anticancer Immunity in the Tumor Microenvironment and Potentiate Efficacy of PD-1 Blockade. The Journal of Immunology. 203(5). 1105–1110. 32 indexed citations
12.
Johnson, Christopher, Brian Riesenberg, Samantha Suriano, et al.. (2018). Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells. Cancer Research. 78(11). 3067–3074. 7 indexed citations
13.
Rachidi, Saleh, Alessandra Metelli, Brian Riesenberg, et al.. (2017). Platelets subvert T cell immunity against cancer via GARP-TGFβ axis. Science Immunology. 2(11). 265 indexed citations
14.
Thaxton, Jessica E., Caroline Wallace, Brian Riesenberg, et al.. (2017). Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function. Cancer Immunology Research. 5(8). 666–675. 33 indexed citations
15.
Ansa-Addo, Ephraim, Yongliang Zhang, Yi Yang, et al.. (2017). Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling. Journal of Clinical Investigation. 127(4). 1321–1337. 53 indexed citations
16.
Ansa-Addo, Ephraim, Jessica E. Thaxton, Hong Feng, et al.. (2016). Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94. Current Topics in Medicinal Chemistry. 16(25). 2765–2778. 81 indexed citations
17.
Johnson, Christopher, Brian Riesenberg, Guangfu Li, et al.. (2015). Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent. Cancer Immunology Research. 3(12). 1364–1374. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026